PAIGE LAUTTENBACH: Open Payments
NPI 1477111615 · GEORGETOWN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 27 payments from 10 companies in 2025. Trend: 2023 $860 · 2024 $354 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $152 |
| Supernus Pharmaceuticals, Inc. | 3 | $137 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| ABBVIE INC. | 4 | $70 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| PFIZER INC. | 2 | $36 |
| Dexcom, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $19 |
| Sonex Health, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: Qelbree, VRAYLAR, AIRSUPRA, Rybelsus, Wegovy, Ozempic, TRELEGY ELLIPTA, Dexcom G6 Transmitter.
Industry payments across SC — which companies pay providers there.
